Vasa Denticity Limited Sets November 6 Results Board Meeting

Vasa Denticity Limited will consider unaudited standalone and consolidated financial results for the half-year ended September 30, 2026, at its board meeting on November 6, following reported June-quarter revenue of ₹83.14 crore and profit after tax of ₹4.12 crore.

What will Vasa Denticity consider at its November 6 board meeting?

Vasa Denticity will consider and approve its unaudited financial results for the period ended September 30, 2026. The company has specifically stated that the agenda includes standalone and consolidated half-yearly results. The disclosure is a board-meeting intimation, not an announcement of the September-period financial outcome.

The meeting is scheduled for November 6, 2026. Its timing follows the close of the first half of the 2026-27 financial year on September 30. Investors will await the eventual filing for the reported half-year revenue, profitability, margins, and any management commentary accompanying the results.

The trading window has been closed from October 1, 2026. Such a closure restricts trading by designated persons during the period when unpublished price-sensitive information relating to the results may be available.

What did Vasa Denticity report in the June 2026 quarter?

Vasa Denticity reported ₹83.14 crore of revenue, ₹5.06 crore of operating EBITDA and ₹4.12 crore of profit after tax for the quarter ended June 30, 2026, according to its investor presentation. The presentation reported year-on-year growth of 37.4% in revenue, 66.6% in operating EBITDA and 49.8% in profit after tax.

The June-quarter operating EBITDA margin was stated at 6.09%, while basic earnings per share were ₹2.36. The financial results were reviewed by the Audit Committee and approved by the Board of Directors on August 7, 2026. KRA & Co., Chartered Accountants, conducted a limited review under Regulation 33 of the SEBI Listing Obligations and Disclosure Requirements Regulations.

A standalone quarterly-results table separately shows sales of ₹82.17 crore, operating profit of ₹5.08 crore and profit before tax of ₹5.31 crore for June 2026. The supplied disclosures use different revenue figures for the same quarter, and no reconciliation between the ₹83.14 crore presentation figure and the ₹82.17 crore standalone sales figure is provided in the available information.

How has Vasa Denticity's recent profitability changed?

Vasa Denticity's June 2026 standalone operating profit was ₹5.08 crore, compared with ₹0.22 crore in March 2026, based on the supplied quarterly table. Operating profit margin improved to 6.18% from 0.30% over the same comparison. Profit before tax rose to ₹5.31 crore from ₹1.67 crore.

The company reported June 2026 standalone sales of ₹82.17 crore, versus ₹72.41 crore in March 2026 and ₹60.02 crore in June 2025. Its June-quarter result therefore followed a period in which sales had grown but operating margins had been variable, including a 2.56% operating margin in December 2025 and 0.30% in March 2026.

In its investor presentation, Vasa Denticity said that gross margin improved for the first time in three quarters. It also said repair work undertaken over the preceding twelve months had started to be reflected in the June-quarter numbers. These remarks provide the company's stated context for the improvement in profitability, while the September results will provide the next disclosed half-year update.

What other corporate developments should investors note?

Vasa Denticity held its 10th Annual General Meeting on September 29, 2026, through video conference. Shareholders adopted financial statements and ratified the cancellation of a proposed acquisition, according to the supplied disclosures. The company submitted the scrutinizer's report and voting results on September 30, with all four resolutions reported as passed.

The company also announced the resignation of Non-Executive Independent Director Ravi Parmeshwar, effective August 7, 2026. Separately, NSE approved the listing of 150,000 shares arising from warrant conversion, with trading stated to begin on November 2, 2026.

Shareholding data supplied for September 2026 shows promoter ownership at 59.65%, compared with 60.19% in March 2026. Foreign institutional investor ownership was 7.67% in September 2026, compared with 6.93% in March 2026. These figures show changes in disclosed ownership categories but do not, by themselves, establish the reasons for buying or selling activity.

Why does the September half-year update matter to investors?

Vasa Denticity's September half-year update matters because it will show whether the higher revenue and profitability reported in the June quarter continued into the next quarter. The company has also identified Digital Dentistry, launched in September 2025, as a business serving clinic-grade equipment demand across intraoral scanners, CAD/CAM milling, 3D printing, imaging and sterilisation.

The upcoming filing can also clarify the relationship between standalone and consolidated performance. Since the board-meeting notice covers both sets of results, investors will be able to assess the reported figures across the two reporting bases once they are released. Until then, the available disclosure confirms only the meeting agenda and not the September-period performance.

Conclusion

Vasa Denticity has scheduled its November 6 board meeting to consider unaudited standalone and consolidated results for the half-year ended September 30, 2026. The meeting follows a June quarter in which the company reported ₹83.14 crore revenue, ₹5.06 crore operating EBITDA and ₹4.12 crore profit after tax in its investor presentation.

The next item to watch is the company's results filing after the board meeting, particularly the reported half-year revenue, margins, profit and any explanation of performance in Digital Dentistry. Investors may also monitor the effect, if any, of the 150,000 warrant-conversion shares approved for listing from November 2, 2026.